{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:49:21Z","timestamp":1761518961468},"reference-count":19,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,12,18]],"date-time":"2009-12-18T00:00:00Z","timestamp":1261094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background and Objectives\u2002<\/jats:bold> Medullary thyroid carcinoma (MTC) is a calcitonin (CT)\u2010secreting neuroendocrine tumour originating from thyroid C cells. Serum CT concentrations are helpful in the early detection of MTC, while it is still unclear whether they can be used also for the differential diagnosis between MTC and C\u2010cell hyperplasia (CCH), a precancerous condition in familial MTCs but with unclear clinical significance in sporadic MTCs. Nowadays, surgery is recommended in all patients with basal or pentagastrin (PG)\u2010stimulated CT value of 100\u2003pg\/ml or more, without discriminating if they are affected with MTC or CCH only. The objective of this study was to investigate the utility of the PG test for CT in distinguishing CCH from MTC before surgery.<\/jats:p><jats:p><jats:bold>Patients and Methods\u2002<\/jats:bold> Sixteen of 20 patients with thyroid nodules and basal CT levels between 15 and 100\u2003ng\/l had a positive PG test (&gt;100\u2003ng\/l PG CT peak) and form the basis of the data analysis. A diagnosis of MTC was histologically proved on surgical samples in seven patients and of CCH in nine other patients. Four patients with neither FNAB nor PG test consistent with a diagnosis of MTC did not undergo thyroidectomy.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> A peak of CT of 275\u2003ng\/l after PG was able to significantly distinguish patients with MTC from patients with CCH, with 100% sensitivity and 89% specificity (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7002). PG\u2010stimulated calcitonin levels &gt;275\u2003ng\/l had a positive predictive value (PPV) value for diagnosis of MTC of 100%, and PG\u2010stimulated calcitonin levels &lt;275 had a PPV for the diagnosis of CCH of 89%.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> A CT cut\u2010off after PG of 275\u2003ng\/l is suggested to be highly predictive in distinguishing CCH from MTC before surgery, and this may be helpful in selecting patients for thyroid surgery.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2009.03759.x","type":"journal-article","created":{"date-parts":[[2009,12,18]],"date-time":"2009-12-18T14:45:21Z","timestamp":1261147521000},"page":"85-88","source":"Crossref","is-referenced-by-count":20,"title":["Predictive value of pentagastrin test for preoperative differential diagnosis between C\u2010cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels"],"prefix":"10.1111","volume":"73","author":[{"given":"F.","family":"Milone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Ramundo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"Chiofalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Severino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Paciolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Pezzullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Colao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Faggiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,6,14]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02037.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2008.0403"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197111112852004"},{"key":"e_1_2_5_5_2","first-page":"995","article-title":"The clinical course after definitive operation for medullary thyroid carcinoma","volume":"94","author":"Jackson C.E.","year":"1983","journal-title":"Surgery"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198205000-00008"},{"key":"e_1_2_5_7_2","first-page":"247","article-title":"Atlas of tumour pathology","author":"Rosai J.","year":"1992","journal-title":"Tumours of the thyroid gland"},{"key":"e_1_2_5_8_2","first-page":"292","volume-title":"Update in Neuroendocrinology. From Basic Research to Clinical Practice","author":"Russo D.","year":"2004"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1590"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2099.102268"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4875"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1380041"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4266(06)72585-9"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870060307"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.1.3707"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199806000-00009"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200110000-00004"},{"key":"e_1_2_5_18_2","first-page":"335","article-title":"The goitrous patient with an elevated serum calcitonin: what to do?","volume":"82","author":"Horwit P.","year":"1997","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031983"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-11-200506070-00011"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2009.03759.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2009.03759.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T15:47:38Z","timestamp":1698767258000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2009.03759.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,14]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1111\/j.1365-2265.2009.03759.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03759.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,14]]}}}